Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Ascendis Pharma (ASND) has released an update. Ascendis Pharma reported a revenue of €57.8 million in Q3 2024, driven by product launches and ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma has released its unaudited financial results for the period ending September 30, ...

Analysing Cytokinetics' potential in the biopharma market with its drug aficamten, projected peak sales of $3.6 billion and ...